Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India

Clinical and Vaccine Immunology

Volumn 18, Issue 2, 2011, Pages 346-348

  Gidwani, Kamlesh ^a   Picado, Albert ^b   Ostyn, Bart ^b   Singh, Shri Prakash ^a   Kumar, Rajiv ^a   Khanal, Basudha ^c   Lejon, Veerle ^b   Chappuis, François ^d   Boelaert, Marleen ^b   Sundar, Shyam ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c B P KOIRALA INSTITUTE OF HEALTH SCIENCES   (Nepal)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; MILTEFOSINE; PROTOZOON ANTIBODY; STIBOGLUCONATE SODIUM;

ADOLESCENT; ADULT; AGED; AGGLUTINATION TEST; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; DIRECT AGGLUTINATION TEST; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INDIA; INFANT; LEISHMANIA DONOVANI; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGGLUTINATION TESTS; ANTIBODIES, PROTOZOAN; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INDIA; INFANT; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79551482876     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00473-10     Document Type: Article

References (17)

1. Bhattacharya, S. K., D. Sur, P. K. Sinha, and J. Karbwang. 2006. Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible & operationally achievable. Indian J. Med. Res. 123:195-196.
2. Bhattarai, N. R., et al. 2009. PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-Azar. Trop. Med. Int. Health 14:404-411.
3. Boelaert, M., et al. 2008. Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. Trans. R. Soc. Trop. Med. Hyg. 102:32-40.
4. De Almeida Silva, L., et al. 2006. Immunologic tests in patients after clinical cure of visceral leishmaniasis. Am. J. Trop. Med. Hyg. 75:739-743.
5. el Harith, A., et al. 1988. Improvement of a direct agglutination test for field studies of visceral leishmaniasis. J. Clin. Microbiol. 26:1321-1325.
6. Hailu, A. 1990. Pre- and post-treatment antibody levels in visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 84:673-675.
7. Jacquet, D., et al. 2006. Comparative evaluation of freeze-dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA-DAT/VL). Trop. Med. Int. Health 11:1777-1784.
8. Khanal, B., et al. Serological markers for Leishmania donovani infection in Nepal: agreement between direct agglutination test and rK39 ELISA. Trop. Med. Int. Health, in press.
9. Kurkjian, K. M., et al. 2005. Application of an improved method for the recombinant K39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh. Clin. Diagn. Lab. Immunol. 12:1410-1415.
10. NVBDCP. Template for developing district action plan (kala-azar), in press. National Vector Borne Disease Control Programme, Delhi, India.
11. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
12. Sharma, U., and S. Singh. 2009. Immunobiology of leishmaniasis. Indian J. Exp. Biol. 47:412-423.
13. Singh, S., V. Kumari, and N. Singh. 2002. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen. Clin. Diagn. Lab. Immunol. 9:568-572.
14. Singh, S. P., et al. 2010. The epidemiology of Leishmania donovani infection in high transmission foci in India. Trop. Med. Int. Health 15(Suppl. 2):12-20.
15. Singh, S. P., D. C. Reddy, M. Rai, and S. Sundar. 2006. Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India. Trop. Med. Int. Health 11:899-905.
16. Thakur, C. P., et al. 2008. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India. Indian J. Med. Res. 128:38-44.
17. Zijlstra, E. E., et al. 1998. rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection. Clin. Diagn. Lab. Immunol. 5:717-720.